Semin intervent Radiol 2018; 35(01): 017-022
DOI: 10.1055/s-0038-1636516
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Updates on MR-Guided Focused Ultrasound for Symptomatic Uterine Fibroids

Divya Sridhar
1   Department of Radiology, NYU Langone Health, New York, New York
,
Maureen P. Kohi
2   Department of Radiology and Biomedical Imaging, University of California, San Francisco, California
› Author Affiliations
Further Information

Publication History

Publication Date:
05 April 2018 (online)

Abstract

Magnetic-resonance–guided focused ultrasound (MRgFUS), also called high-intensity focused ultrasound (HIFU) is an effective, noninvasive uterine-preserving treatment for symptomatic uterine fibroids. As the use of this therapeutic modality is not yet widespread, it may remain unfamiliar to many interventional radiologists. The purpose of this review is to discuss MRgFUS, including technology, patient selection, technique, outcomes, complications, and recent data on fertility and comparative effectiveness.

 
  • References

  • 1 Wallach EE, Vlahos NF. Uterine myomas: an overview of development, clinical features, and management. Obstet Gynecol 2004; 104 (02) 393-406
  • 2 Divakar H. Asymptomatic uterine fibroids. Best Pract Res Clin Obstet Gynaecol 2008; 22 (04) 643-654
  • 3 Jacoby VL, Kohi MP, Poder L. , et al. PROMISe trial: a pilot, randomized, placebo-controlled trial of magnetic resonance guided focused ultrasound for uterine fibroids. Fertil Steril 2016; 105 (03) 773-780
  • 4 Coakley FV, Foster BR, Farsad K. , et al. Pelvic applications of MR-guided high intensity focused ultrasound. Abdom Imaging 2013; 38 (05) 1120-1129
  • 5 Roberts A. Magnetic resonance-guided focused ultrasound for uterine fibroids. Semin Intervent Radiol 2008; 25 (04) 394-405
  • 6 Silberzweig JE, Powell DK, Matsumoto AH, Spies JB. Management of uterine fibroids: a focus on uterine-sparing interventional techniques. Radiology 2016; 280 (03) 675-692
  • 7 Hesley GK, Gorny KR, Woodrum DA. MR-guided focused ultrasound for the treatment of uterine fibroids. Cardiovasc Intervent Radiol 2013; 36 (01) 5-13
  • 8 Mikami K, Murakami T, Okada A, Osuga K, Tomoda K, Nakamura H. Magnetic resonance imaging-guided focused ultrasound ablation of uterine fibroids: early clinical experience. Radiat Med 2008; 26 (04) 198-205
  • 9 Funaki K, Fukunishi H, Funaki T, Sawada K, Kaji Y, Maruo T. Magnetic resonance-guided focused ultrasound surgery for uterine fibroids: relationship between the therapeutic effects and signal intensity of preexisting T2-weighted magnetic resonance images. Am J Obstet Gynecol 2007; 196 (02) 184.e1-184.e6
  • 10 Trumm CG, Stahl R, Clevert DA. , et al. Magnetic resonance imaging-guided focused ultrasound treatment of symptomatic uterine fibroids: impact of technology advancement on ablation volumes in 115 patients. Invest Radiol 2013; 48 (06) 359-365
  • 11 Zhao WP, Chen JY, Zhang L. , et al. Feasibility of ultrasound-guided high intensity focused ultrasound ablating uterine fibroids with hyperintense on T2-weighted MR imaging. Eur J Radiol 2013; 82 (01) e43-e49
  • 12 Smart OC, Hindley JT, Regan L, Gedroyc WM. Magnetic resonance guided focused ultrasound surgery of uterine fibroids--the tissue effects of GnRH agonist pre-treatment. Eur J Radiol 2006; 59 (02) 163-167
  • 13 Wang W, Wang Y, Wang T, Wang J, Wang L, Tang J. Safety and efficacy of US-guided high-intensity focused ultrasound for treatment of submucosal fibroids. Eur Radiol 2012; 22 (11) 2553-2558
  • 14 Park H, Yoon SW, Kim KA, Jung Kim D, Jung SG. Magnetic resonance imaging-guided focused ultrasound treatment of pedunculated subserosal uterine fibroids: a preliminary report. J Vasc Interv Radiol 2012; 23 (12) 1589-1593
  • 15 Hudson SB, Stewart EA. Magnetic resonance-guided focused ultrasound surgery. Clin Obstet Gynecol 2008; 51 (01) 159-166
  • 16 Park MJ, Kim YS, Rhim H, Lim HK. Safety and therapeutic efficacy of complete or near-complete ablation of symptomatic uterine fibroid tumors by MR imaging-guided high-intensity focused US therapy. J Vasc Interv Radiol 2014; 25 (02) 231-239
  • 17 Gorny KR, Borah BJ, Brown DL, Woodrum DA, Stewart EA, Hesley GK. Incidence of additional treatments in women treated with MR-guided focused US for symptomatic uterine fibroids: review of 138 patients with an average follow-up of 2.8 years. J Vasc Interv Radiol 2014; 25 (10) 1506-1512
  • 18 Froeling V, Meckelburg K, Scheurig-Muenkler C. , et al. Midterm results after uterine artery embolization versus MR-guided high-intensity focused ultrasound treatment for symptomatic uterine fibroids. Cardiovasc Intervent Radiol 2013; 36 (06) 1508-1513
  • 19 Froeling V, Meckelburg K, Schreiter NF. , et al. Outcome of uterine artery embolization versus MR-guided high-intensity focused ultrasound treatment for uterine fibroids: long-term results. Eur J Radiol 2013; 82 (12) 2265-2269
  • 20 Kim HS, Baik JH, Pham LD, Jacobs MA. MR-guided high-intensity focused ultrasound treatment for symptomatic uterine leiomyomata: long-term outcomes. Acad Radiol 2011; 18 (08) 970-976
  • 21 Rabinovici J, David M, Fukunishi H, Morita Y, Gostout BS, Stewart EA. ; MRgFUS Study Group. Pregnancy outcome after magnetic resonance-guided focused ultrasound surgery (MRgFUS) for conservative treatment of uterine fibroids. Fertil Steril 2010; 93 (01) 199-209
  • 22 Mara M, Maskova J, Fucikova Z, Kuzel D, Belsan T, Sosna O. Midterm clinical and first reproductive results of a randomized controlled trial comparing uterine fibroid embolization and myomectomy. Cardiovasc Intervent Radiol 2008; 31 (01) 73-85
  • 23 Barnard EP, AbdElmagied AM, Vaughan LE. , et al. Periprocedural outcomes comparing fibroid embolization and focused ultrasound: a randomized controlled trial and comprehensive cohort analysis. Am J Obstet Gynecol 2017; 216 (05) 500.e1-500.e11